These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 32393392)
41. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17. Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827 [TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway. Shi SL; Zhang ZH Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529 [TBL] [Abstract][Full Text] [Related]
43. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo. Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316 [TBL] [Abstract][Full Text] [Related]
44. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145 [TBL] [Abstract][Full Text] [Related]
45. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983 [TBL] [Abstract][Full Text] [Related]
46. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p. Li J; Song Y; Yu B; Yu Y DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459 [TBL] [Abstract][Full Text] [Related]
47. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
48. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway. Chen W; Zhang Y; Fang Z; Qi W; Xu Y Cytokine; 2022 May; 153():155831. PubMed ID: 35301175 [TBL] [Abstract][Full Text] [Related]
49. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024 [TBL] [Abstract][Full Text] [Related]
50. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer. Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. Liu M; Zhang Y; Zhang J; Cai H; Zhang C; Yang Z; Niu Y; Wang H; Wei X; Wang W; Gao P; Li H; Zhang J; Sun G Cell Death Dis; 2018 Feb; 9(2):189. PubMed ID: 29415994 [TBL] [Abstract][Full Text] [Related]
52. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways. Guan L; Zhang L; Wang T; Jia L; Zhang N; Yan H; Zhao K Cancer Biomark; 2021; 32(3):293-302. PubMed ID: 34151840 [TBL] [Abstract][Full Text] [Related]
53. Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A. Luo D; Zhang Z; Zhang Z; Li JY; Cui J; Shi WP; Dong XW; Yuan L; Lin P; Chen ZN; Bian HJ; Wang ZL J Immunol Res; 2018; 2018():1687097. PubMed ID: 30155491 [TBL] [Abstract][Full Text] [Related]
54. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1. Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175 [TBL] [Abstract][Full Text] [Related]
55. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
56. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15. Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080 [TBL] [Abstract][Full Text] [Related]
57. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Wang C; Li S; Xu J; Niu W; Li S Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1. Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281 [TBL] [Abstract][Full Text] [Related]
59. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer. Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Chen D; Guo W; Qiu Z; Wang Q; Li Y; Liang L; Liu L; Huang S; Zhao Y; He X Cancer Lett; 2015 Jul; 362(2):208-17. PubMed ID: 25843294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]